Back

Hippocampal single-cell RNA Atlas of chronic methamphetamine abuse-induced cognitive decline in mice

Qiu, H.; Yue, X.; Huang, Y.; Meng, Z.; Wang, J.; Qiao, D.

2025-05-08 pharmacology and toxicology
10.1101/2025.05.02.651823 bioRxiv
Show abstract

BackgroundChronic methamphetamine abuse leads to cognitive decline, posing a significant threat to human health and contributing to loss of productivity. However, the intricate and multifaceted mechanisms underlying methamphetamine-induced neurotoxicity have impeded the development of effective therapeutic interventions. MethodsTo establish a mouse model of cognitive decline induced by chronic methamphetamine exposure, we employed a large sample size and conducted two behavioral tests (Y-maze and novel object recognition test) at 2 and 4 weeks post-exposure. Subsequently, single-cell RNA sequencing was utilized to delineate the mRNA expression profiles of individual cells within the hippocampus. Comprehensive bioinformatics analyses, including cell clustering and identification, differential gene expression analysis, cellular communication analysis, pseudotemporal trajectory analysis, and transcription factor regulation analysis, were performed to elucidate the cellular-level changes in mRNA profiles caused by chronic methamphetamine exposure. ResultsOur findings demonstrated impairments in working memory, spatial cognition, learning, and cognitive memory. After 4 weeks of behavioral testing, we identified diverse cell types in the hippocampi of METH- and saline-treated mice through scRNA-seq, including glial cells, stromal cells, vascular cells, and immune cells. We observed that methamphetamine exerts cell-specific effects on gene expression changes associated with neuroinflammation, blood-brain barrier disruption, neuronal support dysfunction, and immune dysregulation. Furthermore, cross-talk analysis revealed extensive alterations in cellular communication patterns and signal changes within the hippocampal microenvironment induced by methamphetamine exposure. Pseudotime analysis predicted hippocampal neurogenesis disorders and identified key regulatory genes implicated in chronic methamphetamine abuse. Transcription factor analysis uncovered regulators and pathways linked to astrocyte-mediated neuroinflammation, endothelial junction integrity, microglial synaptic remodeling, and oligodendrocyte-supported neuronal cell bodies and axons. Additionally, it highlighted the role of neural precursor cells in various forms of neurodegeneration. ConclusionsThis study establishes a robust mouse model of cognitive impairment induced by chronic methamphetamine exposure. It provides valuable biological insights, characterizes the single-cell atlas of the hippocampus, and offers novel directions for investigating neurological damage associated with chronic methamphetamine-induced cognitive decline.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
British Journal of Pharmacology
40 papers in training set
Top 0.1%
9.8%
2
ACS Chemical Neuroscience
67 papers in training set
Top 0.1%
8.0%
3
Neurochemistry International
10 papers in training set
Top 0.1%
7.3%
4
Biomedicines
67 papers in training set
Top 0.1%
5.5%
5
Frontiers in Pharmacology
111 papers in training set
Top 0.4%
5.2%
6
Journal of Neurochemistry
53 papers in training set
Top 0.1%
5.2%
7
PLOS ONE
5266 papers in training set
Top 35%
3.5%
8
Toxicological Sciences
41 papers in training set
Top 0.2%
3.5%
9
Scientific Reports
3612 papers in training set
Top 29%
3.5%
50% of probability mass above
10
Alzheimer's Research & Therapy
57 papers in training set
Top 0.7%
2.4%
11
International Journal of Molecular Sciences
494 papers in training set
Top 5%
2.4%
12
Clinical and Translational Medicine
31 papers in training set
Top 0.2%
2.1%
13
Brain, Behavior, and Immunity
116 papers in training set
Top 0.8%
2.1%
14
eLife
5828 papers in training set
Top 48%
1.7%
15
European Journal of Pharmacology
15 papers in training set
Top 0.2%
1.7%
16
The Journal of Pharmacology and Experimental Therapeutics
18 papers in training set
Top 0.2%
1.7%
17
Biological Psychiatry Global Open Science
60 papers in training set
Top 1.0%
1.3%
18
Frontiers in Neuroscience
256 papers in training set
Top 5%
1.1%
19
NeuroToxicology
14 papers in training set
Top 0.2%
1.1%
20
The FASEB Journal
194 papers in training set
Top 4%
1.1%
21
Heliyon
152 papers in training set
Top 6%
1.0%
22
Biomedicine & Pharmacotherapy
42 papers in training set
Top 1%
0.9%
23
Frontiers in Aging Neuroscience
74 papers in training set
Top 2%
0.9%
24
Frontiers in Immunology
638 papers in training set
Top 9%
0.9%
25
Communications Biology
993 papers in training set
Top 29%
0.9%
26
ACS Omega
105 papers in training set
Top 3%
0.9%
27
Journal of Psychiatric Research
32 papers in training set
Top 1%
0.6%
28
Cancers
213 papers in training set
Top 5%
0.6%
29
Nutrients
67 papers in training set
Top 2%
0.6%
30
BMC Medicine
176 papers in training set
Top 6%
0.6%